1. Clinical Overview
A fixed-dose combination analgesic containing Tapentadol, a centrally-acting opioid analgesic with noradrenaline reuptake inhibition, and Paracetamol, a centrally-acting non-opioid analgesic and antipyretic. This combination provides synergistic pain relief for moderate to severe acute pain, targeting both opioid and non-opioid pathways, while potentially allowing for lower opioid doses.
| Onset | Duration | Bioavailability |
|---|---|---|
| Tapentadol: Oral: ~30-60 minutes. Paracetamol: Oral: ~30-60 minutes. | Tapentadol: Approximately 4-6 hours. Paracetamol: Approximately 4-6 hours. | Tapentadol: Approximately 32% (due to significant first-pass metabolism). Paracetamol: Approximately 85-98%. |
2. Mechanism of Action
This combination provides dual analgesic action. Tapentadol exerts its effect through two distinct mechanisms: 1) Agonist activity at the mu-opioid receptor (MOR), and 2) Inhibition of neuronal noradrenaline reuptake (NRI). Paracetamol's exact mechanism is not fully elucidated but is believed to involve central inhibition of prostaglandin synthesis, possibly via COX-2 and COX-3 inhibition, and modulation of the serotonergic and cannabinoid systems. The combination results in synergistic pain relief.
3. Indications & Uses
- Moderate to severe acute pain (e.g., post-operative pain)
- Trauma-related pain (e.g., fractures, sprains)
4. Dosage & Administration
Adult Dosage: One tablet (Tapentadol 50mg + Paracetamol 325mg) every 4-6 hours as needed for pain. The minimum effective dose should be used for the shortest duration. Maximum: 4 tablets in 24 hours (i.e., Tapentadol 200mg + Paracetamol 1300mg).
Administration: Administer orally with or without food. Tablet should be swallowed whole with a glass of water. Do not crush, chew, or break. To minimize GI upset, take with food or milk. Do not consume alcohol.
5. Side Effects
Common side effects may include:
- Nausea
- Vomiting
- Dizziness
- Somnolence (drowsiness)
- Headache
- Constipation
- Dry mouth
- Fatigue
- Sweating
6. Drug Interactions
| Drug | Effect | Severity |
|---|---|---|
| Other Opioids (e.g., Morphine, Codeine), Benzodiazepines (e.g., Alprazolam), Sedatives/Hypnotics (e.g., Zolpidem) | Additive CNS depression, respiratory depression, sedation, coma risk. | Major |
| Alcohol | Increased CNS depression and risk of hepatotoxicity from Paracetamol. | Major |
| Monoamine Oxidase Inhibitors (MAOIs) e.g., Phenelzine, Selegiline | Risk of serotonin syndrome, hyperpyrexia, excitation. Contraindicated. | Major |
| Serotonergic Drugs (SSRIs e.g., Sertraline, SNRIs e.g., Venlafaxine, TCAs, Triptans, Tramadol) | Increased risk of serotonin syndrome. | Major |
| Muscle Relaxants (e.g., Baclofen, Tizanidine) | Enhanced sedative and respiratory depressant effects. | Moderate |
| Anticholinergics (e.g., Atropine, Antihistamines like Diphenhydramine) | Increased risk of urinary retention, severe constipation, CNS depression. | Moderate |
| Antihypertensives, Diuretics | Potentiation of hypotensive effects. | Moderate |
| Warfarin and other Coumarin Anticoagulants | Paracetamol may potentiate anticoagulant effect, increasing INR; monitor closely. | Moderate |
| Enzyme Inducers (e.g., Rifampicin, Carbamazepine, Phenytoin, St. John's Wort) | May reduce Tapentadol efficacy and increase risk of Paracetamol hepatotoxicity by inducing CYP enzymes. | Moderate |
| Probenecid | May decrease Paracetamol conjugation, increasing its levels. | Minor |
| Metoclopramide, Domperidone | May antagonize GI effects of Tapentadol; efficacy may be reduced. | Minor |
7. Patient Counselling
- DO take exactly as prescribed by your doctor.
- DO inform all your doctors and dentists you are taking this medicine.
- DO store safely out of reach of children and pets.
- DO report severe constipation, dizziness, or excessive sleepiness to your doctor.
- DON'T crush, chew, or break the tablet.
- DON'T increase the dose or frequency without consulting your doctor.
- DON'T share this medicine with anyone else.
- DON'T stop abruptly after long-term use; taper as directed to avoid withdrawal.
- DON'T take with other Paracetamol-containing products (cold/flu remedies).
8. Toxicology & Storage
Overdose: Manifestations of Tapentadol overdose: Pinpoint pupils, respiratory depression, somnolence progressing to stupor/coma, skeletal muscle flaccidity, cold/clammy skin, bradycardia, hypotension, circulatory collapse, cardiac arrest, death. Paracetamol overdose: Stage 1 (0-24h): Nausea, vomiting, anorexia, malaise. Stage 2 (24-72h): Right upper quadrant pain, elevated LFTs. Stage 3 (72-96h): Peak hepatotoxicity, jaundice, coagulopathy, encephalopathy, potential renal failure. Stage 4 (4d-2wks): Recovery or death.
Storage: Store at room temperature (15-30°C), protected from light and moisture. Keep in the original blister pack or container. Keep out of reach of children and pets. Do not flush unused medication. Dispose of unused tablets as per local pharmacy take-back programs or guidelines for Schedule H1 drugs.